Did you know that 1 in 100 people live with epilepsy, yet there are still many misconceptions about this neurological disease?
The World Health Organization (WHO) released a report in 2019, simply titled, “Epilepsy: A Public Health Imperative”. We are reaching out to you to join the conversation and invite your schools to Think About Epilepsy!
Epilepsy Durham Region offers in-service presentations that are customizable for all grade levels, teaching epilepsy 101, seizure recognition and first response protocol. The...
During the 2019 federal election campaign, Neurological Health Charities Canada (NHCC) is asking political parties if they will work with us to improve the lives of Canadians affected by brain conditions. NHCC is a coalition of 12 organizations that represent over two million Canadians living with brain conditions (diseases, disorders and injuries). we encourage you to spread the NHCC message during the campaign.
Below are three questions that NHCC is asking all parties and as many candidates as possible. When you have the opportunity to meet candidates, please ask these key questions and then rate them on their answers. Please try to get them to be as specific as possible.
After the discussion, please let NHCC know what you find out. You can email your responses directly to...
Please join us for our 5th annual Epilepsy education forum: Road to New Beginnings | Practical Strategies for Living Well with Epilepsy. This is a full day event with expert guest speakers!
Where: Whitby Public Library | 410 Dundas Street West, Whitby | Room 1A/B
When: Saturday, November 9th | 10:00 am - 2:00 pm
**Please note that you must register to attend this event. There is a $20.00 registration fee, payable to Epilepsy Durham Region which includes your full day of education and a complimentary lunch
Revised: September 10th, 2019
**Excerpt from The Globe And Mail | Kelly Grant · Posted: Aug 23, 2019 | https://tgam.ca/2MEqCaH
A group of pharmaceutical companies is taking the federal government to court over its plan to reduce Canada’s drug prices, arguing Ottawa does not have the constitutional authority to set ceiling prices for medications.
Several prominent drug-makers, including Merck Canada Inc., Janssen Inc. and Boehringer Ingelheim Canada Ltd., filed the constitutional challenge on Friday, two days after the Trudeau government passed final regulations beefing up the powers of the Patented Medicine Prices Review Board (PMPRB,) the agency that controls the prices of brand-name drugs.
Companies have said lower prices will make international drug manufacturers less likely to bring new medications to Canada.
“The changes recently made by the federal government to the...